Cecha
Prominent forehead
Forward prominence of the entire forehead, due to protrusion of the frontal bone.
Podsumowanie
- Znana także jako
- Bulging forehead, Pronounced forehead, Protruding forehead, Prominence of frontal region
- Układ organizmu
- Abnormality of head or neck
Genom referencyjnyGRCh38hg38
Pozycje na stronach genów i wariantów zależą od tego wyboru, w tej przeglądarce.
Read the genes linked to Prominent forehead, and the rest of your genome, with one test.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni
Zamawiam Genome Test283 genów powiązanych z Prominent forehead
Zmiany w tych genach powodują rzadkie choroby, w których występuje Prominent forehead. Większość osób z tą cechą nie ma żadnej z tych chorób, a gen z tej listy nic nie mówi o czyimkolwiek własnym genomie.
| Gen | Jak często występuje | Choroby |
|---|---|---|
| ALDH18A1aldehyde dehydrogenase 18 family member A1 | Zawsze | W 3 chorobach |
| ARID2AT-rich interaction domain 2 | Zawsze | W 1 chorobie |
| ARNT2aryl hydrocarbon receptor nuclear translocator 2 | Zawsze | W 1 chorobie |
| ATIC5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | Zawsze | W 2 chorobach |
| B3GALT6beta-1,3-galactosyltransferase 6 | Zawsze | W 2 chorobach |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Zawsze | W 3 chorobach |
| CDKN1Ccyclin dependent kinase inhibitor 1C | Zawsze | W 2 chorobach |
| CEP57centrosomal protein 57 | Zawsze | W 1 chorobie |
| COG4component of oligomeric golgi complex 4 | Zawsze | W 1 chorobie |
| COL18A1collagen type XVIII alpha 1 chain | Zawsze | W 1 chorobie |
| CREBBPCREB binding lysine acetyltransferase | Zawsze | W 3 chorobach |
| DPH1diphthamide biosynthesis 1 | Zawsze | W 2 chorobach |
| DPH2diphthamide biosynthesis 2 | Zawsze | W 2 chorobach |
| DRG1developmentally regulated GTP binding protein 1 | Zawsze | W 1 chorobie |
| DYNC1H1dynein cytoplasmic 1 heavy chain 1 | Zawsze | W 1 chorobie |
| EDAectodysplasin A | Zawsze | W 1 chorobie |
| ELFN1extracellular leucine rich repeat and fibronectin type III domain containing 1 | Zawsze | W 1 chorobie |
| EP300EP300 lysine acetyltransferase | Zawsze | W 2 chorobach |
| EXOSC2exosome component 2 | Zawsze | W 1 chorobie |
| FAM111AFAM111 trypsin like peptidase A | Zawsze | W 3 chorobach |
| FAT4FAT atypical cadherin 4 | Zawsze | W 1 chorobie |
| FBN1fibrillin 1 | Zawsze | W 1 chorobie |
| FEM1Bfem-1 homolog B | Zawsze | W 1 chorobie |
| FGFR2fibroblast growth factor receptor 2 | Zawsze | W 2 chorobach |
| FGFR3fibroblast growth factor receptor 3 | Zawsze | W 2 chorobach |
| FLNAfilamin A | Zawsze | W 3 chorobach |
| FOXP1forkhead box P1 | Zawsze | W 2 chorobach |
| GOLGA2golgin A2 | Zawsze | W 1 chorobie |
| HMGA2high mobility group AT-hook 2 | Zawsze | W 2 chorobach |
| IFT140intraflagellar transport 140 | Zawsze | W 2 chorobach |
| IL2RAinterleukin 2 receptor subunit alpha | Zawsze | W 1 chorobie |
| IL6STinterleukin 6 cytokine family signal transducer | Zawsze | W 1 chorobie |
| KDM1Alysine demethylase 1A | Zawsze | W 2 chorobach |
| KLHL20kelch like family member 20 | Zawsze | W 1 chorobie |
| KPTNkaptin, actin binding protein | Zawsze | W 2 chorobach |
| MBTPS1membrane bound transcription factor peptidase, site 1 | Zawsze | W 1 chorobie |
| MYCNMYCN proto-oncogene, bHLH transcription factor | Zawsze | W 1 chorobie |
| NALCNsodium leak channel, non-selective | Zawsze | W 1 chorobie |
| OBSL1obscurin like cytoskeletal adaptor 1 | Zawsze | W 1 chorobie |
| PDGFRBplatelet derived growth factor receptor beta | Zawsze | W 1 chorobie |
Pokaż jeszcze 243 genów
| Gen | Jak często występuje | Choroby |
|---|---|---|
| PEPDpeptidase D | Zawsze | W 1 chorobie |
| PEX1peroxisomal biogenesis factor 1 | Zawsze | W 1 chorobie |
| POLR3ARNA polymerase III subunit A | Zawsze | W 1 chorobie |
| PPFIA3PPFI scaffold protein A3 | Zawsze | W 1 chorobie |
| PRPS1phosphoribosyl pyrophosphate synthetase 1 | Zawsze | W 1 chorobie |
| PTDSS1phosphatidylserine synthase 1 | Zawsze | W 1 chorobie |
| PTH1Rparathyroid hormone 1 receptor | Zawsze | W 1 chorobie |
| PUF60poly(U) binding splicing factor 60 | Zawsze | W 2 chorobach |
| PYCR1pyrroline-5-carboxylate reductase 1 | Zawsze | W 2 chorobach |
| RNU5B-1RNA, U5B small nuclear 1 | Zawsze | W 1 chorobie |
| RPS6KA3ribosomal protein S6 kinase A3 | Zawsze | W 3 chorobach |
| RRAGCRas related GTP binding C | Zawsze | W 1 chorobie |
| SCYL2SCY1 like pseudokinase 2 | Zawsze | W 1 chorobie |
| SERPINH1serpin family H member 1 | Zawsze | W 1 chorobie |
| SKIC3SKI3 subunit of superkiller complex | Zawsze | W 2 chorobach |
| SONSON DNA and RNA binding protein | Zawsze | W 2 chorobach |
| SP7Sp7 transcription factor | Zawsze | W 1 chorobie |
| STAT5Bsignal transducer and activator of transcription 5B | Zawsze | W 2 chorobach |
| SUPT7LSPT7 like, STAGA complex subunit gamma | Zawsze | W 1 chorobie |
| TMEM53transmembrane protein 53 | Zawsze | W 1 chorobie |
| TTC7Atetratricopeptide repeat domain 7A | Zawsze | W 1 chorobie |
| VPS33AVPS33A core subunit of CORVET and HOPS complexes | Zawsze | W 2 chorobach |
| ZBTB7Azinc finger and BTB domain containing 7A | Zawsze | W 1 chorobie |
| ZPR1ZPR1 zinc finger | Zawsze | W 1 chorobie |
| FLNBfilamin B | Bardzo często (80–99%) | W 2 chorobach |
| FUCA1alpha-L-fucosidase 1 | Bardzo często (80–99%) | W 2 chorobach |
| GNEglucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | Bardzo często (80–99%) | W 2 chorobach |
| HERC1HECT and RLD domain containing E3 ubiquitin protein ligase family member 1 | Bardzo często (80–99%) | W 2 chorobach |
| IARS2isoleucyl-tRNA synthetase 2, mitochondrial | Bardzo często (80–99%) | W 2 chorobach |
| IGF2insulin like growth factor 2 | Bardzo często (80–99%) | W 4 chorobach |
| MED12mediator complex subunit 12 | Bardzo często (80–99%) | W 3 chorobach |
| MID1midline 1 | Bardzo często (80–99%) | W 2 chorobach |
| NFIXnuclear factor I X | Bardzo często (80–99%) | W 3 chorobach |
| NSD1nuclear receptor binding SET domain protein 1 | Bardzo często (80–99%) | W 2 chorobach |
| PIK3R1phosphoinositide-3-kinase regulatory subunit 1 | Bardzo często (80–99%) | W 2 chorobach |
| PLAG1PLAG1 zinc finger | Bardzo często (80–99%) | W 2 chorobach |
| ROR2ROR family WNT receptor 2 | Bardzo często (80–99%) | W 1 chorobie |
| SH3PXD2BSH3 and PX domains 2B | Bardzo często (80–99%) | W 1 chorobie |
| SHOC2SHOC2 leucine rich repeat scaffold protein | Bardzo często (80–99%) | W 1 chorobie |
| SMOC1SPARC related modular calcium binding 1 | Bardzo często (80–99%) | W 2 chorobach |
| ZBTB18zinc finger and BTB domain containing 18 | Bardzo często (80–99%) | W 2 chorobach |
| ACTL6Bactin like 6B | Często (30–79%) | W 1 chorobie |
| ADAT3adenosine deaminase tRNA specific 3 | Często (30–79%) | W 2 chorobach |
| ADNPactivity dependent neuroprotector homeobox | Często (30–79%) | W 1 chorobie |
| ALX4ALX homeobox 4 | Często (30–79%) | W 1 chorobie |
| AMER1APC membrane recruitment protein 1 | Często (30–79%) | W 1 chorobie |
| APC2APC regulator of Wnt signaling pathway 2 | Często (30–79%) | W 1 chorobie |
| B3GLCTbeta 3-glucosyltransferase | Często (30–79%) | W 2 chorobach |
| CASKcalcium/calmodulin dependent serine protein kinase | Często (30–79%) | W 1 chorobie |
| CDH2cadherin 2 | Często (30–79%) | W 1 chorobie |
| CDKL5cyclin dependent kinase like 5 | Często (30–79%) | W 2 chorobach |
| CKAP2Lcytoskeleton associated protein 2L | Często (30–79%) | W 1 chorobie |
| CNOT3CCR4-NOT transcription complex subunit 3 | Często (30–79%) | W 1 chorobie |
| COL2A1collagen type II alpha 1 chain | Często (30–79%) | W 1 chorobie |
| CTNNB1catenin beta 1 | Często (30–79%) | W 1 chorobie |
| D2HGDHD-2-hydroxyglutarate dehydrogenase | Często (30–79%) | W 1 chorobie |
| DLK1delta like non-canonical Notch ligand 1 | Często (30–79%) | W 3 chorobach |
| DPF2double PHD fingers 2 | Często (30–79%) | W 1 chorobie |
| DVL1dishevelled segment polarity protein 1 | Często (30–79%) | W 1 chorobie |
| DVL3dishevelled segment polarity protein 3 | Często (30–79%) | W 1 chorobie |
| FARSBphenylalanyl-tRNA synthetase subunit beta | Często (30–79%) | W 1 chorobie |
| FZD2frizzled class receptor 2 | Często (30–79%) | W 1 chorobie |
| GLI2GLI family zinc finger 2 | Często (30–79%) | W 1 chorobie |
| GNSglucosamine (N-acetyl)-6-sulfatase | Często (30–79%) | W 1 chorobie |
| GPAA1glycosylphosphatidylinositol anchor attachment 1 | Często (30–79%) | W 2 chorobach |
| GPC4glypican 4 | Często (30–79%) | W 1 chorobie |
| GRB10growth factor receptor bound protein 10 | Często (30–79%) | W 1 chorobie |
| H19H19 imprinted maternally expressed transcript | Często (30–79%) | W 2 chorobach |
| INPPL1inositol polyphosphate phosphatase like 1 | Często (30–79%) | W 1 chorobie |
| IRX5iroquois homeobox 5 | Często (30–79%) | W 1 chorobie |
| KDM6Blysine demethylase 6B | Często (30–79%) | W 1 chorobie |
| KIAA0753KIAA0753 | Często (30–79%) | W 1 chorobie |
| KIDINS220kinase D interacting substrate 220 | Często (30–79%) | W 2 chorobach |
| KMT2Alysine methyltransferase 2A | Często (30–79%) | W 1 chorobie |
| KRASKRas proto-oncogene, GTPase | Często (30–79%) | W 1 chorobie |
| LRP4LDL receptor related protein 4 | Często (30–79%) | W 1 chorobie |
| MAP2K1mitogen-activated protein kinase kinase 1 | Często (30–79%) | W 1 chorobie |
| MAP2K2mitogen-activated protein kinase kinase 2 | Często (30–79%) | W 1 chorobie |
| MAPKAPK5MAPK activated protein kinase 5 | Często (30–79%) | W 1 chorobie |
| MARS2methionyl-tRNA synthetase 2, mitochondrial | Często (30–79%) | W 1 chorobie |
| MEG3maternally expressed 3 | Często (30–79%) | W 3 chorobach |
| MN1MN1 proto-oncogene, transcriptional regulator | Często (30–79%) | W 1 chorobie |
| NPR2natriuretic peptide receptor 2 | Często (30–79%) | W 2 chorobach |
| NSD2nuclear receptor binding SET domain protein 2 | Często (30–79%) | W 1 chorobie |
| PDE4Dphosphodiesterase 4D | Często (30–79%) | W 1 chorobie |
| PIGLphosphatidylinositol glycan anchor biosynthesis class L | Często (30–79%) | W 1 chorobie |
| PKDCCprotein kinase domain containing, cytoplasmic | Często (30–79%) | W 1 chorobie |
| PMM2phosphomannomutase 2 | Często (30–79%) | W 2 chorobach |
| PPP1CBprotein phosphatase 1 catalytic subunit beta | Często (30–79%) | W 1 chorobie |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Często (30–79%) | W 1 chorobie |
| PRMT7protein arginine methyltransferase 7 | Często (30–79%) | W 2 chorobach |
| PTENphosphatase and tensin homolog | Często (30–79%) | W 1 chorobie |
| RAF1Raf-1 proto-oncogene, serine/threonine kinase | Często (30–79%) | W 1 chorobie |
| RAI1retinoic acid induced 1 | Często (30–79%) | W 1 chorobie |
| RMRPRNA component of mitochondrial RNA processing endoribonuclease | Często (30–79%) | W 1 chorobie |
| RTL1retrotransposon Gag like 1 | Często (30–79%) | W 3 chorobach |
| RYR3ryanodine receptor 3 | Często (30–79%) | W 1 chorobie |
| SATB2SATB homeobox 2 | Często (30–79%) | W 1 chorobie |
| SKISKI proto-oncogene | Często (30–79%) | W 1 chorobie |
| SKIC2SKI2 subunit of superkiller complex | Często (30–79%) | W 2 chorobach |
| SMG9SMG9 nonsense mediated mRNA decay factor | Często (30–79%) | W 2 chorobach |
| SPECC1Lsperm antigen with calponin homology and coiled-coil domains 1 like | Często (30–79%) | W 2 chorobach |
| STAT3signal transducer and activator of transcription 3 | Często (30–79%) | W 2 chorobach |
| SUZ12SUZ12 polycomb repressive complex 2 subunit | Często (30–79%) | W 1 chorobie |
| TAF1TATA-box binding protein associated factor 1 | Często (30–79%) | W 1 chorobie |
| THSD1thrombospondin type 1 domain containing 1 | Często (30–79%) | W 1 chorobie |
| TMEM147transmembrane protein 147 | Często (30–79%) | W 1 chorobie |
| TWIST1twist family bHLH transcription factor 1 | Często (30–79%) | W 1 chorobie |
| UBR7ubiquitin protein ligase E3 component n-recognin 7 | Często (30–79%) | W 1 chorobie |
| VPS35LVPS35 endosomal protein sorting factor like | Często (30–79%) | W 1 chorobie |
| WASHC4WASH complex subunit 4 | Często (30–79%) | W 1 chorobie |
| WNT5AWnt family member 5A | Często (30–79%) | W 1 chorobie |
| ZBTB20zinc finger and BTB domain containing 20 | Często (30–79%) | W 1 chorobie |
| AGR2anterior gradient 2, protein disulphide isomerase family member | Czasami (5–29%) | W 1 chorobie |
| AP1G1adaptor related protein complex 1 subunit gamma 1 | Czasami (5–29%) | W 1 chorobie |
| ARCN1archain 1 coat protein complex I subunit delta | Czasami (5–29%) | W 1 chorobie |
| ARXaristaless related homeobox | Czasami (5–29%) | W 1 chorobie |
| ASXL3ASXL transcriptional regulator 3 | Czasami (5–29%) | W 2 chorobach |
| BRWD3bromodomain and WD repeat domain containing 3 | Czasami (5–29%) | W 1 chorobie |
| CA2carbonic anhydrase 2 | Czasami (5–29%) | W 1 chorobie |
| CAMK2Bcalcium/calmodulin dependent protein kinase II beta | Czasami (5–29%) | W 1 chorobie |
| CBFBcore-binding factor subunit beta | Czasami (5–29%) | W 1 chorobie |
| CDC42cell division cycle 42 | Czasami (5–29%) | W 2 chorobach |
| CLCN3Cl-/H+ antiporter 3 | Czasami (5–29%) | W 1 chorobie |
| CRELD1CRELD disulfide isomerase 1 | Czasami (5–29%) | W 1 chorobie |
| DHCR2424-dehydrocholesterol reductase | Czasami (5–29%) | W 1 chorobie |
| DONSONDNA replication fork stabilization factor DONSON | Czasami (5–29%) | W 1 chorobie |
| DOT1LDOT1 like histone lysine methyltransferase | Czasami (5–29%) | W 1 chorobie |
| DPH5diphthamide biosynthesis 5 | Czasami (5–29%) | W 1 chorobie |
| DPYDdihydropyrimidine dehydrogenase | Czasami (5–29%) | W 1 chorobie |
| EBF3EBF transcription factor 3 | Czasami (5–29%) | W 1 chorobie |
| EDARectodysplasin A receptor | Czasami (5–29%) | W 1 chorobie |
| EDARADDEDAR associated via death domain | Czasami (5–29%) | W 1 chorobie |
| ELNelastin | Czasami (5–29%) | W 1 chorobie |
| ERMARDER membrane associated RNA degradation | Czasami (5–29%) | W 1 chorobie |
| EXT2exostosin glycosyltransferase 2 | Czasami (5–29%) | W 1 chorobie |
| FAM149B1family with sequence similarity 149 member B1 | Czasami (5–29%) | W 1 chorobie |
| FBLN5fibulin 5 | Czasami (5–29%) | W 1 chorobie |
| FBXL4F-box and leucine rich repeat protein 4 | Czasami (5–29%) | W 1 chorobie |
| FBXO31F-box protein 31 | Czasami (5–29%) | W 1 chorobie |
| FGFR1fibroblast growth factor receptor 1 | Czasami (5–29%) | W 1 chorobie |
| FOXC1forkhead box C1 | Czasami (5–29%) | W 1 chorobie |
| H3-3AH3.3 histone A | Czasami (5–29%) | W 1 chorobie |
| H3-3BH3.3 histone B | Czasami (5–29%) | W 1 chorobie |
| HECTD4HECT domain E3 ubiquitin protein ligase 4 | Czasami (5–29%) | W 1 chorobie |
| HESX1HESX homeobox 1 | Czasami (5–29%) | W 1 chorobie |
| IGF1insulin like growth factor 1 | Czasami (5–29%) | W 1 chorobie |
| JARID2jumonji and AT-rich interaction domain containing 2 | Czasami (5–29%) | W 1 chorobie |
| KDF1keratinocyte differentiation factor 1 | Czasami (5–29%) | W 1 chorobie |
| KICS2KICSTOR subunit 2 | Czasami (5–29%) | W 1 chorobie |
| KIF11kinesin family member 11 | Czasami (5–29%) | W 1 chorobie |
| KMT2Dlysine methyltransferase 2D | Czasami (5–29%) | W 1 chorobie |
| LARP7La ribonucleoprotein 7, transcriptional regulator | Czasami (5–29%) | W 1 chorobie |
| LHX3LIM homeobox 3 | Czasami (5–29%) | W 1 chorobie |
| LHX4LIM homeobox 4 | Czasami (5–29%) | W 1 chorobie |
| LRP6LDL receptor related protein 6 | Czasami (5–29%) | W 1 chorobie |
| LRPPRCleucine rich pentatricopeptide repeat containing | Czasami (5–29%) | W 1 chorobie |
| MAN2B1mannosidase alpha class 2B member 1 | Czasami (5–29%) | W 1 chorobie |
| MARK2microtubule affinity regulating kinase 2 | Czasami (5–29%) | W 1 chorobie |
| MDGA2MAM domain containing glycosylphosphatidylinositol anchor 2 | Czasami (5–29%) | W 1 chorobie |
| MED16mediator complex subunit 16 | Czasami (5–29%) | W 1 chorobie |
| MEGF8multiple EGF like domains 8 | Czasami (5–29%) | W 1 chorobie |
| MTORmechanistic target of rapamycin kinase | Czasami (5–29%) | W 1 chorobie |
| PITX2paired like homeodomain 2 | Czasami (5–29%) | W 1 chorobie |
| POU1F1POU class 1 homeobox 1 | Czasami (5–29%) | W 2 chorobach |
| PPP2R5Cprotein phosphatase 2 regulatory subunit B'gamma | Czasami (5–29%) | W 1 chorobie |
| PPP2R5Dprotein phosphatase 2 regulatory subunit B'delta | Czasami (5–29%) | W 1 chorobie |
| PRKDCprotein kinase, DNA-activated, catalytic subunit | Czasami (5–29%) | W 1 chorobie |
| PROP1PROP paired-like homeobox 1 | Czasami (5–29%) | W 1 chorobie |
| PURApurine rich element binding protein A | Czasami (5–29%) | W 2 chorobach |
| RECQL4RecQ like helicase 4 | Czasami (5–29%) | W 1 chorobie |
| RYR1ryanodine receptor 1 | Czasami (5–29%) | W 1 chorobie |
| SIN3ASIN3 transcription regulator family member A | Czasami (5–29%) | W 1 chorobie |
| SRPK3SRSF protein kinase 3 | Czasami (5–29%) | W 1 chorobie |
| SVBPsmall vasohibin binding protein | Czasami (5–29%) | W 1 chorobie |
| TONSLtonsoku like, DNA repair protein | Czasami (5–29%) | W 1 chorobie |
| TRAF6TNF receptor associated factor 6 | Czasami (5–29%) | W 1 chorobie |
| UPF3BUPF3B regulator of nonsense mediated mRNA decay | Czasami (5–29%) | W 1 chorobie |
| USP9Xubiquitin specific peptidase 9 X-linked | Czasami (5–29%) | W 3 chorobach |
| WACWW domain containing adaptor with coiled-coil | Czasami (5–29%) | W 3 chorobach |
| ZFXzinc finger protein X-linked | Czasami (5–29%) | W 1 chorobie |
| ZNF292zinc finger protein 292 | Czasami (5–29%) | W 1 chorobie |
| ZNF711ZFX family zinc finger ZNF711 | Czasami (5–29%) | W 1 chorobie |
| ZSWIM6zinc finger SWIM-type containing 6 | Czasami (5–29%) | W 1 chorobie |
| AP2M1adaptor related protein complex 2 subunit mu 1 | Rzadko (1–4%) | W 1 chorobie |
| CHD2chromodomain helicase DNA binding protein 2 | Rzadko (1–4%) | W 1 chorobie |
| CNTNAP2contactin associated protein 2 | Rzadko (1–4%) | W 1 chorobie |
| CTCFCCCTC-binding factor | Rzadko (1–4%) | W 1 chorobie |
| EPG5ectopic P-granules 5 autophagy tethering factor | Rzadko (1–4%) | W 1 chorobie |
| GJA5gap junction protein alpha 5 | Rzadko (1–4%) | W 1 chorobie |
| GJA8gap junction protein alpha 8 | Rzadko (1–4%) | W 1 chorobie |
| GJB2gap junction protein beta 2 | Rzadko (1–4%) | W 1 chorobie |
| GJB6gap junction protein beta 6 | Rzadko (1–4%) | W 1 chorobie |
| NEXMIFneurite extension and migration factor | Rzadko (1–4%) | W 1 chorobie |
| SCN1Asodium voltage-gated channel alpha subunit 1 | Rzadko (1–4%) | W 1 chorobie |
| SLC2A1solute carrier family 2 member 1 | Rzadko (1–4%) | W 1 chorobie |
| SLC6A1solute carrier family 6 member 1 | Rzadko (1–4%) | W 1 chorobie |
| SYNGAP1synaptic Ras GTPase activating protein 1 | Rzadko (1–4%) | W 1 chorobie |
| ABCC9ATP binding cassette subfamily C member 9 | Nie odnotowano | W 1 chorobie |
| AP1S2adaptor related protein complex 1 subunit sigma 2 | Nie odnotowano | W 1 chorobie |
| ASXL1ASXL transcriptional regulator 1 | Nie odnotowano | W 1 chorobie |
| B3GAT3beta-1,3-glucuronyltransferase 3 | Nie odnotowano | W 1 chorobie |
| CCND2cyclin D2 | Nie odnotowano | W 1 chorobie |
| CHD3chromodomain helicase DNA binding protein 3 | Nie odnotowano | W 1 chorobie |
| CHST3carbohydrate sulfotransferase 3 | Nie odnotowano | W 1 chorobie |
| COL27A1collagen type XXVII alpha 1 chain | Nie odnotowano | W 1 chorobie |
| CPT2carnitine palmitoyltransferase 2 | Nie odnotowano | W 1 chorobie |
| EFEMP2EGF-like fibulin extracellular matrix protein 2 | Nie odnotowano | W 1 chorobie |
| ERFETS2 repressor factor | Nie odnotowano | W 1 chorobie |
| FAM50Afamily with sequence similarity 50 member A | Nie odnotowano | W 1 chorobie |
| GLE1GLE1 RNA export mediator | Nie odnotowano | W 1 chorobie |
| HECW2HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 | Nie odnotowano | W 1 chorobie |
| HRASHRas proto-oncogene, GTPase | Nie odnotowano | W 1 chorobie |
| IFT81intraflagellar transport 81 | Nie odnotowano | W 1 chorobie |
| INPP5Einositol polyphosphate-5-phosphatase E | Nie odnotowano | W 1 chorobie |
| ITGA3integrin subunit alpha 3 | Nie odnotowano | W 1 chorobie |
| KCNJ1potassium inwardly rectifying channel subfamily J member 1 | Nie odnotowano | W 1 chorobie |
| KIF7kinesin family member 7 | Nie odnotowano | W 1 chorobie |
| KMT2Elysine methyltransferase 2E (inactive) | Nie odnotowano | W 1 chorobie |
| LBRlamin B receptor | Nie odnotowano | W 1 chorobie |
| MAB21L2mab-21 like 2 | Nie odnotowano | W 1 chorobie |
| MED13Lmediator complex subunit 13L | Nie odnotowano | W 1 chorobie |
| MYH3myosin heavy chain 3 | Nie odnotowano | W 1 chorobie |
| NAA10N-alpha-acetyltransferase 10, NatA catalytic subunit | Nie odnotowano | W 1 chorobie |
| NANSN-acetylneuraminate synthase | Nie odnotowano | W 1 chorobie |
| NRASNRAS proto-oncogene, GTPase | Nie odnotowano | W 1 chorobie |
| OPHN1oligophrenin 1 | Nie odnotowano | W 1 chorobie |
| PAM16presequence translocase associated motor 16 | Nie odnotowano | W 1 chorobie |
| PEX5peroxisomal biogenesis factor 5 | Nie odnotowano | W 1 chorobie |
| PIGKphosphatidylinositol glycan anchor biosynthesis class K | Nie odnotowano | W 1 chorobie |
| PLA2G6phospholipase A2 group VI | Nie odnotowano | W 1 chorobie |
| POC1APOC1 centriolar protein A | Nie odnotowano | W 1 chorobie |
| RALARAS like proto-oncogene A | Nie odnotowano | W 1 chorobie |
| SETBP1SET binding protein 1 | Nie odnotowano | W 1 chorobie |
| SETD2SET domain containing 2, histone lysine methyltransferase | Nie odnotowano | W 1 chorobie |
| SNX14sorting nexin 14 | Nie odnotowano | W 1 chorobie |
| SRCAPSnf2 related CREBBP activator protein | Nie odnotowano | W 1 chorobie |
| SUMF1sulfatase modifying factor 1 | Nie odnotowano | W 1 chorobie |
| TAPT1transmembrane anterior posterior transformation 1 | Nie odnotowano | W 1 chorobie |
| TBCEtubulin folding cofactor E | Nie odnotowano | W 1 chorobie |
| TRIP11thyroid hormone receptor interactor 11 | Nie odnotowano | W 1 chorobie |
| TRRAPtransformation/transcription domain associated protein | Nie odnotowano | W 1 chorobie |
| UNC80unc-80 subunit of NALCN channel complex | Nie odnotowano | W 1 chorobie |
Jak często występuje wśród osób z jedną z chorób związanych z tym genem, najczęściej spośród wszystkich, według danych Human Phenotype Ontology. Te strony opisują cechy i badania, na których się opierają; nie są diagnozą, a w sprawie objawów należy zwrócić się do lekarza lub doradcy genetycznego.
Cechy nadrzędne
Skąd pochodzą te dane
- Human Phenotype Ontology, wydanie 2026-09-01: cecha, jej nazwy, definicja oraz geny z nią powiązane. Więcej informacji znajdą Państwo na stronie hpo.jax.org.
- Wydanie danych 2026.10.16-c6eea6bf.
Jeden test. Odpowiedzi na całe życie.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni